Every Form 4 that Lumexa Imaging Holdings, Inc. (LMRI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow LMRI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LMRI filings page.
Mittl Robert Louis Jr. reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings, Inc. director Robert Louis Mittl Jr. received an equity award in the form of restricted stock units. He was granted 19,358 RSUs, each representing the right to receive one share of Lumexa common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of Lumexa’s stockholders, as long as he continues serving the company. Following this award, he holds 19,358 shares/units directly, reflecting compensation rather than an open-market share purchase or sale.
Lungren Matthew reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings, Inc. reported that director Matthew Lungren received a grant of 19,358 restricted stock units (RSUs) of common stock. The award was recorded at a price of $0.00 per share because it is a stock-based compensation grant, not an open-market purchase.
The RSUs represent the right to receive an equal number of common shares and will vest on the earlier of one year from the grant date or the next annual stockholder meeting, as long as Lungren continues serving the company. After this grant, he directly holds 19,358 common shares tied to this award.
Karlin Bridget E reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings, Inc. director Bridget E. Karlin received an equity grant of 19,358 restricted stock units (RSUs), each representing one share of common stock. The award was granted at no cash cost per unit and is a form of stock-based compensation rather than an open-market purchase.
The RSUs will vest on the earlier of one year from the grant date or the next annual stockholder meeting, provided she continues serving the company. Following this grant, her reported direct holding related to this award is 19,358 shares/RSUs, aligning her compensation more closely with shareholder value.
Lumexa Imaging Holdings, Inc. director Joseph Molly reported an equity compensation grant. He acquired 19,358 shares of common stock at a price of $0.00 per share as a grant or award, increasing his direct holdings to 46,385 shares.
The award is structured as restricted stock units, each representing the right to receive one share of common stock. These RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, as long as Molly continues to serve the company.
EISENBERG GLENN A reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings, Inc. director Glenn A. Eisenberg received an equity compensation grant of 19,358 restricted stock units (RSUs) of common stock on June 10, 2026. Each RSU represents the right to receive one share of common stock if vesting conditions are met.
The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of Lumexa Imaging’s stockholders, subject to Eisenberg’s continued service with the company. Following this award, he holds 19,358 shares/RSUs directly according to the filing.
Cooper Henry Lee reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings director Cooper Henry Lee reported a compensation-related equity grant and his indirect holdings. He received 19,358 shares of common stock as restricted stock units at $0.00 per share, which vest on the earlier of one year from grant or the next annual stockholder meeting, subject to continued service. Following this grant, he holds 19,358 shares directly and 30,000 shares indirectly through the Cooper Family Trust, where he and his spouse are co-trustees, with beneficial ownership of the trust shares disclaimed except for his pecuniary interest.
BRODNAX BRETT reported acquisition or exercise transactions in this Form 4 filing.
Lumexa Imaging Holdings director Brett Brodnax received a grant of 19,358 restricted stock units (RSUs) of common stock. The award was made at no cash cost per unit and increases his direct holdings to 81,385 shares. The RSUs vest on the earlier of one year from the grant date or the next annual stockholder meeting, as long as he continues serving the company.
Lumexa Imaging Holdings director Brett Brodnax reported an open-market purchase of 35,000 shares of Common Stock at $7.25 per share. Following this transaction, he directly owns 62,027 Lumexa Imaging Holdings shares, according to the Form 4 insider filing.
Lumexa Imaging Holdings director-related trust buys shares
Cooper Family Trust, a revocable trust for which director Cooper Henry Lee and his spouse serve as co-trustees, purchased 30,000 shares of Lumexa Imaging Holdings, Inc. common stock in an open-market transaction at a weighted average price of $7.4371 per share on May 14, 2026.
Following the purchase, the trust holds 30,000 shares indirectly attributed to Lee. He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
Lumexa Imaging Holdings, Inc. reported that its Principal Accounting Officer, Walker James Edward Jr., acquired 12,414 shares of common stock in the form of restricted stock units. The grant carried a price of $0.0000 per share, indicating it was an equity award rather than an open-market purchase.
Each RSU represents the contingent right to receive one share of Lumexa common stock. The RSUs vest in three substantially equal annual installments on each of the first three anniversaries of the grant date, conditioned on Mr. Walker’s continued service with the company. Following this award, his directly owned common stock and RSUs total 17,346 shares.
Lumexa Imaging Holdings, Inc. reported that its Chief Financial Officer, Martin James Anthony, received two grants of common-stock-based compensation on December 12, 2025. Each grant covers 27,027 restricted stock units (RSUs) at a price of $0 per share, for a total of 54,054 RSUs now beneficially owned directly.
One RSU grant vests in three roughly equal annual installments on each of the first three anniversaries of the grant date, as long as he remains with the company. The second grant vests in three equal parts if the stock reaches volume-weighted average price targets of $27.00, $36.00 and $45.00 over any 60‑trading‑day period within up to four years, also subject to continued service.
Lumexa Imaging Holdings, Inc. reported that its Chief Executive Officer and director received two equity awards on December 12, 2025 totaling 129,728 restricted stock units (RSUs), each RSU representing one share of common stock. Each grant covers 64,864 RSUs at an acquisition price of $0 per share.
The first 64,864 RSUs vest in three substantially equal annual installments on each of the first three anniversaries of the grant date, subject to the executive’s continued service. The second 64,864 RSUs vest in three substantially equal installments upon achieving stock price targets of $27.00, $36.00 and $45.00 per share, based on 60‑trading‑day volume weighted average prices over measurement periods that can extend to the fourth anniversary of the grant, also requiring continued service.
Lumexa Imaging Holdings, Inc. reported that a director acquired 27,027 restricted stock units, each representing the contingent right to receive one share of the company’s common stock, on December 12, 2025 at a price of $0 per unit.
Following this grant, the reporting person is shown as beneficially owning 27,027 shares of common stock. The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the reporting person’s continued service with the company.
Lumexa Imaging Holdings, Inc. reported that a company director acquired 27,027 shares of common stock on 12/12/2025 through a restricted stock unit grant at a price of $0 per share. Following this grant, the director beneficially owns 27,027 shares held directly.
The award consists of restricted stock units, each representing the contingent right to receive one share of common stock. Of these units, 13,513 vested on the grant date, and the remaining units are scheduled to vest in three substantially equal annual installments on each of the first three anniversaries of the grant date, subject to the director’s continued service with the company.
Lumexa Imaging Holdings, Inc. reported that its Chief Medical Officer, as an officer of the company, acquired a total of 8,464 restricted stock units (RSUs) representing shares of common stock on 12/12/2025 at a price of $0 per share, resulting in beneficial ownership of 8,464 shares held directly.
One grant of 4,232 RSUs vests annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to continued service. A second grant of 4,232 RSUs vests in three substantially equal installments upon reaching stock price targets of $27.00, $36.00 and $45.00 per share, measured by the volume weighted average closing price over any 60 consecutive trading days within a period that begins after a 180-day lock-up and runs to the three-year anniversary, with unachieved targets remaining eligible to vest through the four-year anniversary.
Lumexa Imaging Holdings, Inc. reported insider equity activity for its Chief Legal Officer and Corporate Secretary, Julie Szeker, dated December 12, 2025. A transaction coded “M” involved 1,250,000 incentive units of Lumexa Imaging Equity Holdco, LLC tied to 66,182 shares of common stock, which, according to the footnotes, had been converted into stock at the closing of the company’s initial public offering with replacement awards subject to time- and performance-based vesting conditions.
Following the reported activity, Szeker directly beneficially owned 147,263 shares of common stock, including 11,876 shares that vest only if the stock reaches a volume-weighted average price of $24.97 over a 60-trading-day period after the IPO lock-up expires, subject to continued service. She also holds 81,081 restricted stock units, each representing one share of common stock, scheduled to vest in full on December 12, 2026, provided she continues serving the company.